Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis

Atherosclerosis

Volumn 231, Issue 1, 2013, Pages 29-38

  Paland, Nicole ^a   Aharoni, Saar ^a   Fuhrman, Bianca ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Apoptosis; Atherosclerosis; Differentiation; Macrophages; Monocytes; UPA

Indexed keywords

BIM PROTEIN; CALCIUM; CD36 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; STAUROSPORINE; THAPSIGARGIN; UROKINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATTENUATION; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; ATHEROSCLEROSIS; DIFFERENTIATION; MACROPHAGES; MONOCYTES; UPA;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENDOPLASMIC RETICULUM STRESS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; LIPOPROTEINS, LDL; MACROPHAGES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; MONOCYTES; TETRADECANOYLPHORBOL ACETATE; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84885355805     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.08.016     Document Type: Article

References (48)

1. Moore K.J., Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011, 145(3):341-355.
2. Vicca S., Hennequin C., Nguyen-Khoa T., et al. Caspase-dependent apoptosis in THP-1 cells exposed to oxidized low-density lipoproteins. Biochem Biophys Res Commun 2000, 273(3):948-954.
3. Wintergerst E.S., Jelk J., Rahner C., Asmis R. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3. Eur J Biochem 2000, 267(19):6050-6059.
4. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010, 10:36-46.
5. Leist M., Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2001, 2:589-598.
6. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 1998, 60:619-642.
7. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008, 9:47-59.
8. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
9. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
10. Scull C.M., Tabas I. Mechanisms of ER stress-induced apoptosis in atherosclerosis. Arterioscler Thromb Vasc Biol 2011, 31:2792-2797.
11. Yao S., Zong C., Zhang Y., et al. Activating transcription factor 6 mediates oxidized LDL-induced cholesterol accumulation and apoptosis in macrophages by up-regulating CHOP expression. JAtheroscler Thromb 2013, 20(1):94-107.
12. Waltz D.A., Fujita R.M., Yang X., et al. Nonproteolytic role for the urokinase receptor in cellular migration invivo. Am J Respir Cell Mol Biol 2000, 22:316-322.
13. Wei Y., Lukashev M., Simon D.I., et al. Regulation of integrin function by the urokinase receptor. Science 1996, 273:1551-1555.
14. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. JBiol Chem 1994, 269:32380-32388.
15. Liu D., Aguirre Ghiso J., Estrada Y., Ossowski L. EGFR is a transducer of the urokinase receptor initiated signal that is required for invivo growth of a human carcinoma. Cancer Cell 2002, 1:445-457.
16. Kiyan J., Kiyan R., Haller H., Dumler I. Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-beta. EMBO J 2005, 24:1787-1797.
17. Kienast J., Padro T., Steins M., et al. Relation of urokinase-type plasminogen activator expression to presence and severity of atherosclerotic lesions in human coronary arteries. Thromb Haemost 1998, 79:579-586.
18. Cozen A.E., Moriwaki H., Kremen M., et al. Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death. Circulation 2004, 109:2129-2135.
19. Fuhrman B., Nitzan O., Karry R., Volkova N., Dumler I., Aviram M. Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. Atherosclerosis 2007, 195:e108-e116.
20. Fuhrman B., Khateeb J., Shiner M., et al. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism. Arterioscler Thromb Vasc Biol 2008, 28:1361-1367.
21. Alfano D., Franco P., Vocca I., et al. The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis. Thromb Haemost 2005, 93:205-211.
22. Tkachuk N., Kiyan J., Tkachuk S., et al. Urokinase induces survival or pro-apoptotic signals in human mesangial cells depending on the apoptotic stimulus. Biochem J 2008, 415(2):265-273.
23. Prager G.W., Mihaly J., Brunner P.M., Koshelnick Y., Hoyer-Hansen G., Binder B.R. Urokinase mediates endothelial cell survival via induction of the X-linked inhibitor of apoptosis protein. Blood 2009, 113(6):1383-1390.
24. Ma Z., Webb D.J., Jo M., Gonias S.L. Endogenously produced urokinase-type plasminogen activator is a major determinant of the basal level of activated ERK/MAP kinase and prevents apoptosis in MDA-MB-231 breast cancer cells. JCell Sci 2001, 114(Pt 18):3387-3396.
25. Luikart S., Masri M., Wahl D., et al. Urokinase is required for the formation of mactinin, an alpha-actinin fragment that promotes monocyte/macrophage maturation. Biochim Biophys Acta 2002, 1591(1-3):99-107.
26. Nusrat A.R., Chapman H.A. An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines. JClin Invest 1991, 87(3):1091-1097.
27. Fuhrman B., Partoush A., Volkova N., Aviram M. Ox-LDL induces monocyte-to-macrophage differentiation invivo: possible role for the macrophage colony stimulating factor receptor (M-CSF-R). Atherosclerosis 2008, 196:598-607.
28. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990, 9:515-554.
29. Bradford M.M. Arapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
30. Kuwakado K., Kubota M., Hirota H., et al. Aphidicolin potentiates apoptosis induced by arabinosyl nucleosides in human myeloid leukemia cell lines. Biochem Pharmacol 1993 Dec 3, 46(11):1909-1916.
31. Ziegler-Heitbrock H.W., Thiel E., Futterer A., Herzog V., Wirtz A., Riethmuller G. Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 1988, 41:456-461.
32. Erl W., Weber C., Wardemann C., Weber P.C. Adhesion properties of Mono Mac 6, a monocytic cell line with characteristics of mature human monocytes. Atherosclerosis 1995, 113:99-107.
33. Ermak N., Lacour B., Goirand F., Drüeke T.B., Vicca S. Differential apoptotic pathways activated in response to Cu-induced or HOCl-induced LDL oxidation in U937 monocytic cell line. Biochem Biophys Res Commun 2010, 393(4):783-787.
34. Fuhrman B., Gantman A., Khateeb J., et al. Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-beta. Cardiovasc Res 2009, 84:145-154.
35. Heo J.-I., Oh S.-J., Kho Y.-J., et al. ERK mediates anti-apoptotic effect through phosphorylation and cytoplasmic localization of p21Waf1/Cip1 in response to DNA damage in normal human embryonic fibroblast (HEF) cells. Mol Biol Rep 2011, 38:2785-2791.
36. Ley R., Balmanno K., Hadfield K., Weston C., Cook S.J. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. JBiol Chem 2003, 278(21):18811-18816.
37. O'Connor L., Strasser A., O'Reilly L.A., et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998, 17(2):384-395.
38. Vallabhaneni K.C., Tkachuk S., Kiyan Y., et al. Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells. Cardiovasc Res 2011, 90(1):113-121.
39. Ohta H., Sweeney E.A., Masamune A., Yatomi Y., Hakomori S., Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res 1995, 55(3):691-697.
40. Giovannini C., Varì R., Scazzocchio B., et al. OxLDL induced p53-dependent apoptosis by activating p38MAPK and PKCδ signaling pathways in J774A.1 macrophage cells. Mol Cell Biol 2011, 3(5):316-318.
41. Namgaladze D., Kollas A., Brüne B. Oxidized LDL attenuates apoptosis in monocytic cells by activating ERK signaling. JLipid Res 2008, 49(1):58-65.
42. Boullier A., Li Y., Quehenberger O., et al. Minimally oxidized LDL offsets the apoptotic effects of extensively oxidized LDL and free cholesterol in macrophages. Arterioscler Thromb Vasc Biol 2006, 26(5):1169-1176.
43. Gautier E.L., Huby T., Witztum J.L., et al. Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage. Circulation 2009, 119(13):1795-1804.
44. Liu J., Thewke D.P., Su Y.R., Linton M.F., Fazio S., Sinensky M.S. Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol 2005, 25(1):174-179.
45. Kockx M.M., Herman A.G. Apoptosis in atherogenesis: implications for plaque destabilization. Eur Heart J 1998, 19(Suppl.G):G23-G28.
46. Lin J., Li H., Yang M., et al. Arole of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell Rep 2013, 3(1):200-210.
47. Secchiero P., Candido R., Corallini F., et al. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation 2006, 114(14):1522-1530.
48. Farris S.D., Hu J.H., Krishnan R., et al. Mechanisms of urokinase plasminogen activator (uPA)-mediated atherosclerosis: role of the uPA receptor and S100A8/A9 proteins. JBiol Chem 2011, 286(25):22665-22677.